1. Home
  2. NOTV vs VRA Comparison

NOTV vs VRA Comparison

Compare NOTV & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • VRA
  • Stock Information
  • Founded
  • NOTV 1974
  • VRA 1982
  • Country
  • NOTV United States
  • VRA United States
  • Employees
  • NOTV N/A
  • VRA N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • VRA Apparel
  • Sector
  • NOTV Health Care
  • VRA Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • VRA Nasdaq
  • Market Cap
  • NOTV 62.5M
  • VRA 61.7M
  • IPO Year
  • NOTV 1997
  • VRA 2010
  • Fundamental
  • Price
  • NOTV $2.12
  • VRA $2.06
  • Analyst Decision
  • NOTV Strong Buy
  • VRA Strong Buy
  • Analyst Count
  • NOTV 1
  • VRA 2
  • Target Price
  • NOTV $5.00
  • VRA $4.00
  • AVG Volume (30 Days)
  • NOTV 385.1K
  • VRA 215.7K
  • Earning Date
  • NOTV 08-06-2025
  • VRA 09-10-2025
  • Dividend Yield
  • NOTV N/A
  • VRA N/A
  • EPS Growth
  • NOTV N/A
  • VRA N/A
  • EPS
  • NOTV N/A
  • VRA N/A
  • Revenue
  • NOTV $480,402,000.00
  • VRA $355,671,000.00
  • Revenue This Year
  • NOTV $4.99
  • VRA N/A
  • Revenue Next Year
  • NOTV $5.39
  • VRA $3.80
  • P/E Ratio
  • NOTV N/A
  • VRA N/A
  • Revenue Growth
  • NOTV N/A
  • VRA N/A
  • 52 Week Low
  • NOTV $1.15
  • VRA $1.71
  • 52 Week High
  • NOTV $6.48
  • VRA $6.38
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 52.04
  • VRA 46.26
  • Support Level
  • NOTV $1.86
  • VRA $1.83
  • Resistance Level
  • NOTV $2.15
  • VRA $2.33
  • Average True Range (ATR)
  • NOTV 0.19
  • VRA 0.15
  • MACD
  • NOTV 0.01
  • VRA -0.03
  • Stochastic Oscillator
  • NOTV 54.86
  • VRA 37.29

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: